Table 1 Baseline Characteristics.
Parameter | Control (n = 46) | Non-DMI (n = 59) | DMI (n = 54) | P value |
|---|---|---|---|---|
Gender (male/female)† | 16/30 | 46/13 | 33/21 | 0.014 |
Age (year)‡ | 52(47.25, 59) | 55(46, 63) | 56(49, 62) | 0.41 |
Duration of DM (year)§ | N/A | 2(1, 9) | 8(1, 13) | 0.04 |
BCVA (LogMAR)§ | N/A | 0.1(0, 0.1) | 0.1(0, 0.2) | < 0.001 |
Hb1Ac (mg/dl)§ | N/A | 9.300(7,400, 11.400) | 9.45(7.725, 11.400) | < 0.001 |
CCFA (μm2)‡ | 2.119(2.073, 2.196) | 2.072(1.995, 2.158) | 1.945(1.752, 2.063) | < 0.001 |
FAZ-A (mm2)‡ | 0.364(0.274, 0.42) | 0.287(0.239, 0.37) | 0.373(0.24, 0.456) | 0.023 |
FAZ-P (μm)‡ | 2.441(2.063, 2.601) | 2.224(1.962, 2.46) | 2.487(2.069, 2.807) | 0.02 |
FAZ-CI‡ | 0.793(0.758, 0.814) | 0.756(0.715, 0.813) | 0.738(0.699, 0.779) | < 0.001 |
SCP‡ | ||||
SCP (whole) (%) | 48.25(46.475, 50.1) | 46.9(44.4, 48.3) | 44.75(41.85, 46.9) | < 0.001 |
SCP (fovea) (%) | 14.25(11.625, 18.9) | 15.7(12.8, 19.6) | 13.4(9.7, 18.325) | 0.082 |
SCP (parafovea) (%) | 51.85(50.075, 52.9) | 49.7(47.3, 51.4) | 47.95(43.425, 50.2) | < 0.001 |
DCP‡ | ||||
DCP (whole) (%) | 53.25(51.875, 55.025) | 51.1(48.7, 53.1) | 50.1(44.475, 52.35) | < 0.001 |
DCP (fovea) (%) | 29.75(24.175, 34.425) | 31.5(26.5, 35.5) | 27.45(22.15, 31.3) | 0.009 |
DCP (parafovea) (%) | 55.3(54.275, 57.3) | 53.5(50.6, 55.7) | 52.2(46.575, 54.725) | < 0.001 |
Inner retinal thickness (μm)‡ | 40(35.75, 47) | 44(39, 47) | 40(36, 49) | 0.26 |
Outer retinal thickness (μm)‡ | 198.5(193, 208) | 203(195, 209) | 203(191, 215) | 0.24 |
Scan quality‡ | 8.5(8, 9) | 8(8, 9) | 8(7, 9) | 0.313 |